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Abstract. Raman scattering is the inelastic scattering of light by chemical bonds, and can therefore show molecular specificity.
It can be used both in pure spectroscopy mode, and in imaging mode. While many applications of Raman spectroscopy and
imaging in the biomedical field have been so far demonstrated, the use of this technology for pathology applications is still in
its early stages. In this paper we review some of the most important recent developments in this field, including a description of
relevant technologies, applications to molecular sensing, characterization of cells and tissues of interest, and disease detection
via Raman scattering.
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1. Introduction
Raman scattering occurs by the inelastic scatter-
ing of photons by molecular bonds. In this scattering
event a small fraction of the incident photons exchange
energy with the molecular vibration and are scattered.
The scattered photons can either be red-shifted by pro-
viding energy to the bond vibration (“Stokes” Raman
scattering) or blue-shifted by receiving energy from the
bond (“anti-Stokes” Raman scattering), with the dif-
ference in energy between the incident and scattered
photons corresponding to the energy of the molec-
ular vibration. Detection of these scattered photons
yields a spectrum containing several Raman peaks,
each of which being characteristic of a specific molecu-
lar bond. Collectively, these peaks provide an intrinsic
“molecular fingerprint” of the sample (the Raman
spectrum), resulting in a wealth of information about
the chemical bonds associated with various molecules
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present in tissues and cells. This information can
be used in different biomedical applications, such as
(i) analysis of chemical composition (DNS, RNA,
lipids, proteins, etc.) and presence of certain molec-
ular markers (sensors and assays), (ii) study of the
interactions between macromolecules (DNA-protein,
protein-lipid interactions), (iii) monitoring biological
functions (lipid uptake, enzymatic activity, neuro-
logical function, mapping of intracellular chemical
environment), (iv) diagnosis and characterization of
disease (cancer, atherosclerotic plaques), or (v) label
free microscopy and endoscopy [1].
While chemical specificity without the use of labels,
noninvasiveness, and the very good spatial resolution
are the main advantages of Raman scattering based
techniques, there are significant drawbacks related
to the weak signal, the usually much stronger flu-
orescence background, and the limited penetration
depth typical for optical techniques. Several Raman-
based techniques have been developed to address these
limitations and perform measurements in different sit-
uations in which biomedical samples can be found.
Spontaneous Raman spectroscopy is mostly used
in the near-infrared region where laser damage and
excitation of autofluorescence is minimal and light
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penetrates deeper into tissue. This technique is very
suitable for applications such as monitoring changes
in cellular composition as a function of malignancy, or
classification of cells and bacteria. The signal obtained
in these situations is, however, very weak, and sev-
eral techniques have been developed to increase the
intensity of the Raman scattering signal.
One way is to choose the excitation wavelength
within the electronic resonance (absorption band) of a
certain molecule. In this case the process is called Res-
onance Raman Scattering (RRS) and the Raman signal
will increase by up to 5 orders of magnitude. However,
it is usually associated with a much stronger fluores-
cence background, and additional approaches such as
ultrafast optical switches, background subtraction, spa-
tially offset Raman scattering, or multi-excitation are
needed for the rejection of this background. Among
these techniques, time-gated Raman spectroscopy at
high repetition rates and low energy per pulse has great
promise, as it may allow the detection of resonance
Raman signals of biological specimens [2].
Other techniques such as Coherent Anti-Stokes
Raman Scattering (CARS) and Stimulated Raman
Scattering (SRS) allow for additional coherent ampli-
fication of the Raman signal and can be used either in
resonance or out of resonance with the electronic states
of the molecule. The CARS signal is generated when
two lasers are focused into the sample, one acting as
the source leading to Stokes-shifted Raman scattering,
while the other one is tuned to the same frequency as a
specific Raman peak [3, 4]. The two lasers interact
nonlinearly within their overlap volume, simultane-
ously exciting the characteristic chemical vibration,
and driving the amplification of the corresponding anti-
Stokes peak. The resulting CARS signal is more than
a thousand times stronger than the original Raman sig-
nal and can be used for chemically selective imaging
without the use of fluorescent tags or dyes. By signif-
icantly reducing the exposure time required to record
the signal, CARS holds great promise for imaging
living cells and tissues. The SRS signal is generated
by the coherent interaction of a pump and a Stokes
beam, whereas the difference between their frequen-
cies matching the frequency of a Raman vibration. As
a result of coherent excitation of molecular vibrations,
the intensity of the pump beam decreases and that of
the Stokes beam increases. While these changes are
very small compared with the initial laser intensities,
high-frequency modulation techniques are needed to
record a useful signal [5, 6]. Due to the lack of a non-
resonant background (which typically plagues CARS),
this techniques claims great promise for video-rate
in vivo label free molecular imaging.
Surface Enhanced Raman Scattering (SERS) is
another way to amplify the Raman signal by the
presence of metallic nanoparticles that exhibit plas-
mon resonance. In SERS, molecules adsorbed onto
the surface of these nanoparticles show strong Raman
enhancement, up to 15 orders of magnitude, due to
the generation of an enhanced electric field around the
particle and charge transfer mechanism. The nanopar-
ticles must be on the order of tens of nanometers
in diameter to exhibit plasmon resonance, and the
excitation wavelength has to be within this plasmon
resonance in order to achieve enhancement. Aggrega-
tion of the nanoparticles, as well as their shape can
shift the position of the plasmon resonance. Due to
extremely large enhancement factors, Raman spec-
tra of single molecules can be detected, which makes
this technique attractive for biosensing. Additionally,
SERS can yield molecular structural information, has
the potential to be broadly multiplexed, and has the
unique ability to improve the specificity of detection by
distinguishing between specific and non-specific bind-
ing events [7]. Molecular beacon assays measuring
combined fluorescence and SERS signals of a reporter
molecule were developed for the detection of human
viral RNA [8], while an aptamer-based SERS sensor
using methylene blue as a Raman probe was devel-
oped for thrombin detection [9]. Folic acid in water and
human serum was detected in this way by using silver
nanoparticles created via ethylene-diaminetetraacetic
acid reduction [10]. It was also shown that very low
concentrations of melamine in food could be detected
using commercially available SERS-active substrates
[11]. The prospect of label-free DNA detection in
high-density arrays is discussed in [12] by using a
SERS platform based on island film lithography com-
bined with silver deposition by galvanic exchange.
By using small, specific oligonucleotide sequences,
Pal et al. developed a SERS gene probe for breast
cancer [13].
In this article we will highlight applications of
various Raman techniques to problems in pathology
ranging in scale from the in vitro analysis of single cells
to the in vivo spectroscopy and imaging of tissues and
entire organisms. Figure 1 briefly summarizes typical
spectra that can be obtained with Raman spectroscopy
on various tissue components, ranging from bacteria
and cells to skin and bone.
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Fig. 1. Typical Raman spectra of various tissue components. A) T-cell; B) streptococcus pneumoniae; C) bovine tendon; D) porcine bone
matrix; E) porcine yellow marrow; F) gray human hair; G) human skin epithelial tissue. All spectra were measured with a home-built Raman
spectrometer with excitation at 785 nm.
2. Data processing methods in vibrational
spectroscopy
Obtaining high quality results from home-built (and
commercial) Raman systems is not always a trivial
matter, as Raman spectra may be contaminated by flu-
orescence backgrounds, or may have been collected
with low signal-to-noise in order to minimize exposure
times (especially for imaging or clinical applications).
Furthermore, Raman spectra from biological samples
are typically composed of multiple overlapping peaks
due to the chemically rich nature of biological tissues.
Therefore assessing differences in spectra from differ-
ent samples or different regions within a sample may
necessitate the use of data processing and analysis tech-
niques that may not be familiar to a non-spectroscopist.
The signal challenge in most spontaneous Raman
spectroscopy applications is background correction,
which must be done in a consistent and appropriate
way to ensure that spectral differences are real and not
artifact. A common technique is to model the back-
ground as a slowly varying function that can be well
approximated by a low-order polynomial, which is
then subtracted from the spectrum. Various schemes
to estimate the polynomial function exist, with by far
the most common being the modified polyfit method
devised by Lieber and Mahadevan-Jansen [14]. This
method works well for featureless backgrounds, but
can fail in cases where a spectral contaminant is sharply
featured. An extension to the modified polyfit to
account for known (sharply featured) spectral contam-
inants was developed by Beier and Berger [15]. Other,
more complex methods also exist, such as shifted-
excitation-difference Raman spectroscopy (SERDS)
and the related Modulated Raman Scattering technique
[16, 17]. Both techniques aim to eliminate the back-
ground by means of slightly changing the excitation
wavelength between two or more sequential acquisi-
tions. Because the Raman peaks will shift along with
the excitation wavelength while the background will
largely stay fixed, finding the difference between the
sequential frames will yield a derivative of the original,
background free spectrum.
After corrected spectra are obtained, one is typi-
cally left with a large dataset consisting of several tens
to hundreds of spectra, each spectrum typically hun-
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dreds to thousands of wavenumbers long. In order to
efficiently reduce this data to only the most valuable
information, a technique known as Principal Compo-
nents Analysis (PCA) is used. Although a thorough
treatment of PCA would involve a detailed discussion
using linear algebra, the technique can be concisely
summarized in the following way. Consider a com-
plicated spectrum consisting of many different peaks.
For different samples these peaks’ intensities and posi-
tions may shift, corresponding to chemical differences
between the samples. However, each peak is not likely
to move independently, as each individual chemical
within the system is represented by multiple peaks, and
multiple chemicals are often varying in tandem. Prin-
cipal Components Analysis seeks to tease out which
pixels vary together, and how much does their vari-
ation explain the variation of the dataset as a whole.
PCA composes a new linear model of the spectral
dataset where each spectrum is represented by dif-
ferent concentrations of Principal Components, where
the first component are those grouped variations that
explain the most variance in the dataset. After that com-
ponent is removed, the second Principal Component
describes the most variation of what is left, and so on.
In most well designed experiments, one would expect
the variation between groups of interest to be one of
the dominant sources of variance. Therefore, PCA is
a sensible technique to discover those differences. In
this way, a spectrum formerly composed of thousands
of datapoints can be reduced to two or three princi-
pal component concentration values (or scores) that
are sufficient to describe all of the relevant data con-
tained within that spectrum. Plotting each spectrum
in a two or three dimensional space defined by the
principal component scores can then allow very intu-
itive visualization of the differences between groups, as
shown in Fig. 2, adapted from Ref. [18]. PCA belongs
to a class of techniques that can be grouped under the
heading of multivariate data reduction methods that all
have as their goal the distillation of a spectrum into
a few numbers that succinctly describe its chemical
information.
Often what is desired in a spectroscopy application
is not any detailed information about chemical or spec-
tral content, but rather to assign a sample into one of
several groups (healthy vs. diseased, bacterial type or
strain, etc.). Often the differences between these groups
may be subtle and not always amenable to a crude
visual analysis. In such cases the spectra (or their rel-

























































Fig. 2. Principal component scatter plots comparing normal and
leukemic (a) T cells and (b) B cells. Adapted with permission from
Ref. 18.
classification algorithm. Several are common, includ-
ing logistic regression [19], neural networks [20], and
support vector machines [21], to name a few. All take
spectra or scores as inputs, and then through various
linear and nonlinear data transformations attempt to
create diagnostic functions that exaggerate between
group differences while minimizing within group dif-
ferences. A training set, where group member status
is known for each spectrum, is used to derive the
diagnostic functions. Following training, validation
sets may be used to evaluate performance and ensure
that robust and reproducible results are obtained, as
well as to quantify the expected classification errors.
Each spectrum in the validation set is placed within
one of several a priori defined groups, occasionally
with Bayesian probabilities attached to the confidence
with which the spectrum was classified. Utilizing these
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“supervised” techniques can provide quantitative esti-
mations of group membership based on chemical
content as reported by the Raman spectrum.
A related class of classification techniques falls
under the heading of “unsupervised” classifiers. These
can be particularly valuable in imaging and other appli-
cations where a priori groups are unknown. A common
unsupervised technique is called hierarchical cluster
analysis (HCA). Cluster analysis represents each spec-
trum as a single point in a high dimensional space,
where each axis represents one pixel on the spec-
trum, and the location along that axis represents the
intensity of the spectrum at that pixel. Pairwise dis-
tances are calculated between each spectrum and each
other spectrum within the dataset. Spectra whose pair-
wise distances indicate they are grouped together are
assigned to one cluster, with the number of clusters
being a user-selected variable. These techniques are
valuable in imaging applications where there are hun-
dreds or thousands of pixels that may all have fairly
low signal-to-noise spectra associated with them (due
to short integration times per pixel to keep the image
acquisition times manageable). Using HCA, an image
can be false colored based on the cluster a pixel is
assigned to. The spectra of all pixels belonging to a sin-
gle cluster can be averaged together to create a single
“cluster” spectrum with correspondingly high signal to
noise [22]. A second unsupervised technique is known
as vertex component analysis (VCA). Understanding
VCA requires us to introduce the concept of a sim-
plex. A simplex is a geometric shape whose number of
vertices is one greater than the dimension in which it
resides. For example, in a 2-dimensional plane, a sim-
plex would be a triangle (3 vertices). In a 3-dimensional
volume, a simplex would be a pyramid (4 vertices). As
in HCA, each spectrum is represented as a point in a
high dimensional space. All of the spectra in a dataset
can be thought of as occupying a geometric volume
within that space. A simplex can be constructed such
that it totally encloses the dataset while at the same
time having a minimum total volume. The vertices of
this simplex correspond to spectra, the “vertex com-
ponent spectra”. Each spectrum in the dataset can be
constructed by mixing different concentrations of these
vertex components. Again, in imaging, a pixel can be
false-colored depending on the concentrations of each
vertex component within that pixel. Although being
perhaps conceptually more challenging than HCA, the
assumptions underlying VCA are actually more rea-
sonable. In HCA the assumption is that each pixel
represents a spectrum of some pure class, and each
spectrum is either representative of one class or another
but in all cases is assumed to be 100% representative
of that cluster. With VCA the assumption is that each
spectrum is a linear superposition of several possi-
ble classes, with each spectrum sharing membership
among several classes in varying proportions. This
flexibility has led to increasing adoption of the VCA
technique [23].
Raman spectra report on chemical content of sam-
ples, and as such can be exceedingly information-rich.
However beneficial this information richness is, it can
be a major challenge to extract the useful informa-
tion from the wealth provided by the Raman spectrum.
To accomplish this, many spectroscopists turn to
multivariate data reduction and classification tech-
niques such as those described above. Although these
techniques (and others not described) have relative
advantages, disadvantages, and caveats associated with
them, they are essential for utilizing Raman spectra to
their full advantage in answering biological and med-
ical questions.
3. Raman spectroscopy for cellular analysis
and imaging
Single cell Raman spectroscopy has gained dramat-
ically in adoption since it was first demonstrated in the
seminal paper by Puppels et al. published in the jour-
nal “Nature” in 1990 [24]. One of the main reasons
why Raman spectroscopy has seen particularly explo-
sive growth in the area of analysis, spectroscopy, and
imaging of single cells can be explained by its unique
strength in nondestructively analyzing the biochemi-
cal composition and metabolic states of cells without
the need for exogenous probes, such as fluorescent
molecules. Even more remarkable is that this analy-
sis is achieved on length scales similar to those made
accessible by confocal fluorescence microscopy [25].
3.1. Requirements for Raman cell analysis
Key to achieving the sensitivity to probe individual
cells by Raman spectroscopy is the ability to reject
background signals as effectively as possible. This has
first been demonstrated by combining laser Raman
spectroscopy with confocal microscope optics [26]. In
confocal microscopy a laser beam is focused to a tight,
diffraction-limited spot (∼250 nm diameter), which
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is then magnified by the microscope optics and pro-
jected onto a confocal pinhole of 50–100 m diameter.
By requiring that the scattered light from the focused
laser spot has to be funneled through this pinhole, any
contributions or background signals from out-of-focus
regions in the sample are automatically blocked by the
pinhole and will not contribute to the signal spectrum.
In more recent implementations the pinhole is often
replaced by the core of a multimode optical fiber into
which the Raman-scattered light is coupled. The fiber
then delivers the scattered light to a grating spectrom-
eter with an ultra-sensitive CCD camera for spectral
data acquisition.
For practical reasons red to infrared laser light has
proven to be most effective for obtaining single cell
Raman spectra. This is mostly due to the fact that
blue or green laser wavelengths lead to the excitation
of substantial auto-fluorescence from the cells. It has
also been shown that wavelengths below ∼600 nm are
typically harmful to cells [27] because they are sig-
nificantly absorbed by various cellular components,
such as proteins, amino acids, nucleic acids, or metabo-
lites leading to either the photo-decomposition of these
molecules or the generation of reactive oxygen species.
Nonetheless, impressive examples of cellular imag-
ing at wavelengths in the blue and green part of the
optical spectrum have been demonstrated - however,
typically on fixed cells. Implementations of cellular
Raman spectroscopy can extend on length scales from
zero dimensions (point mapping) to four-dimensional
imaging where changes in local cellular states are
monitored with time. In its simplest implementation,
specific locations within a cell can be addressed either
by manually selecting them with a micrometer-driven
positioning stage or by point-by-point scanning and
acquiring full Raman spectra for every spot location. A
variation of this concept that can overcome background
contributions has recently also gained popularity. In
this case, the laser power used to induce Raman scat-
tering is increased to the point where it can optically
trap a cell by effectively functioning as a single beam
optical tweezers [28–30]. Laser tweezers Raman spec-
troscopy (LTRS) as this concept has been termed, has
the added benefit that cells can be analyzed several
tens of microns away from any solid substrate, thus
further reducing any background signals from such
optical surfaces. Certain cellular buffer solutions, such
as phosphate buffered saline (PBS) or Tris buffer have
minimal to no Raman background while allowing us to
keep cells in a somewhat arrested metabolic state. This
enables the spectroscopic characterization of living
non-adherent cells in their natural environment. Typ-
ically, LTRS utilizes mostly far-red to infrared lasers
due to the aforementioned toxicity of lower laser wave-
lengths and the relatively high power levels required for
optical trapping [29–31].
A more efficient way of acquiring Raman data across
an entire cell is made possible by line scanning where
a one-dimensional sample area (line) is illuminated
and then imaged onto the entrance slit of an imaging
spectrometer [32]. With a CCD camera of sufficient
height (typically at least 400 lines vertically) as detec-
tor this allows for the simultaneous acquisition of
Raman spectra from many sample points along the
line. This concept is only limited by the laser power
applied to the sample, the spatial resolution of the
spectroscopy system, and potential crosstalk within the
imaging spectrometer. By sweeping the line illumi-
nation across the sample image data can be acquired
with significantly higher speed than with the point
scanning technique. Lastly, Raman data can also be
acquired by point scanning or wide-field illumination
of the sample and imaging the sample through a narrow
band-pass filter to isolate specific Raman resonances
of interest [33]. By utilizing several such narrow fil-
ters or by utilizing a single filter with a tunable laser
source, ratiometric Raman imaging is made possible,
where spectral peaks of interest can be isolated and
their behavior monitored with time. This mechanism,
however, obviously doesn’t allow for the acquisition
of entire spectra for each pixel of the CCD chip. To
make such an application possible, the band-pass fil-
ter would have to be tunable across a spectral range
of interest. This can be achieved by utilizing electro-
or acousto-optic tunable filters, or by angle-tuning of
custom-made interference filters.
For completeness, we should note that over the
last decade coherent Raman imaging methods have
become increasingly popular for cellular imaging
[3, 4, 34]. Here, a combination of pico- or femtosec-
ond pulsed lasers is utilized to probe specific Raman
resonances, e.g. those of lipid vibrations, very effi-
ciently. One laser typically provides the pump beam
that induces Raman scattering. The second laser beam
is then tuned to a Raman resonance of interest (rela-
tive to the wavelength of the pump laser) and probes
this Raman vibration by inducing stimulated emis-
sion of Raman-scattered photons which can either be
detected directly by lock-in techniques (leading to
stimulated Raman scattering, or SRS [35]) or which,
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when combined with an additional pump photon leads
to the emission of anti-Stokes Raman scattered pho-
tons (coherent anti-Stokes Raman scattering, CARS
[3, 4]). Due to the use of short-pulsed lasers, this leads
to the coherent probing of many Raman-active groups
with the same vibrational mode simultaneously, and
thus significantly stronger signals when compared to
spontaneous Raman scattering with continuous-wave
laser beams. By combining broadband femtosecond
lasers with picosecond lasers, an entire region of the
Raman spectrum can also be probed very efficiently.
These techniques, however, require significant invest-
ments in laser infrastructure and, at least for now, the
employment or consultation of experts in the operation
of such lasers.
A particular problem with ultra-sensitive sponta-
neous Raman spectroscopy at the cellular level is that
despite our best efforts in minimizing background con-
tributions, adherent cells naturally have to grow on a
substrate, which leads to Raman scattering in the sub-
strate. While confocal microscope optics rejects much
of this [36], it also typically requires the use of micro-
scope objectives with high numerical aperture (NA).
The most widely used choices are water immersion
lenses (1.2 NA) or oil immersion lenses (1.4 NA).
These, however require thin transparent substrates,
such as glass coverslips with a nominal thickness
between 150–220 m, through which the sample is
probed. Coverslips made from standard glass, such as
BK7, are widely available but generate rather strong
background signals from Raman scattering in the glass.
This is acceptable if the cellular signals to be mea-
sured are equally strong, e.g. from intracellular lipid
droplets. LTRS overcomes this problem by “lifting”
and suspending the cells far enough above the substrate
(∼30 m) while also requiring high NA optics. For-
tunately, substrates with significantly lower intrinsic
Raman scattering are available as well, e.g. coverslips
made from fused silica (quartz), or magnesium fluoride
(MgF2) - albeit at very significant cost. Alternatively,
metal mirrors or extended transparent substrates, i.e.
CaF2 can also be used, but require upright microscope
designs and lower NA lenses.
In the first demonstration of single cell Raman
spectroscopy, Puppels and coworkers utilized confo-
cal optics to demonstrate that they could obtain Raman
spectra from different locations within the same cell
and that these spectra reflect the expected local cellular
biochemistry (e.g. the nucleus exhibits contributions
mostly from DNA and proteins, whereas the cytoplasm
exhibits mostly protein signals, as well as contribu-
tions from metabolites, such as sugars [24]. They also
demonstrated the ability to obtain spectra from iso-
lated chromosomes. While, in the years to come, this
research group was mostly isolated in its pursuit of sin-
gle cell Raman spectroscopy, other researchers began
to “see the light” in the mid to late 1990 s and soon a
large number of Raman scattering studies at the cel-
lular levels started to be published. These include the
study of immune cells [37, 38] and their behavior upon
encountering foreign objects, such as phagocytosis of
antibody-coated beads by macrophages [39], assess-
ing apoptosis [40], the characterization of differences
in the Raman signature between normal and cancer-
ous cells [41–43], or the analysis and identification of
microbial cultures [44, 45].
For example, Chan and co-workers [42] demon-
strated better than 98% sensitivity in their ability to
separate live hematopoietic cells from immortalized,
neoplastic cell lines utilizing laser tweezers confocal
Raman micro-spectroscopy and principal component
analysis. They found that differences between normal
and cancer cells were quantified mostly based on dif-
ferences in the local cellular concentration and the
relative ratios of DNA and protein vibrations. Immor-
talized cell lines will inherently show less variation
in individual cell spectra than pathological samples
obtained from patients which led the same group to
further demonstrate that they could identify individual
leukemic T and B cells in blood samples obtained from
juvenile leukemia patients [46]. Similarly, other groups
have recently shown that they are able to distinguish
cells obtained from various tumors (brain, pancreas,
liver, etc.) from normal cells opening up the potential
to develop Raman spectroscopy into a universal anal-
ysis tool without the need for expensive reagents with
limited shelf life [43, 47, 48]. A remaining challenge
to analyzing cells by spontaneous Raman spectroscopy
is the relatively long signal integration time required
to obtain useful Raman spectra from individual cells,
which can range from seconds to minutes. Broadband
coherent Raman scattering utilizing either CARS or
SRS might eventually replace this mechanism if suit-
able and cost-effective means can be found to integrate
short-pulsed lasers with rapid flow analysis. The holy
grail of this technique is, of course, the hunt for and
the identification of rare cells, such as circulating tumor
cells or circulating stem cells.
On the subcellular scale, intracellular compart-
ments, vesicles, organelles and macromolecular
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complexes are typically the target of Raman spec-
troscopy. In particular, the analysis of lipid-cell
interactions in living cells, the main problem under-
lying most lipid disorders in humans, has become one
of the leading objectives of intracellular Raman spec-
troscopy. This is mostly due to the fact that cells that
are exposed to an abundance of lipids, such as free fatty
acids, diglycerides, and triglycerides often develop
lipid inclusions, or lipid droplets, in their cytoplasm as
part of their response mechanism to fight lipotoxicity.
Because of the sample concentration requirement of
spontaneous Raman spectroscopy, lipid droplets rep-
resent ideal targets for Raman-based analysis because
they typically accumulate lipids in concentrated form
as spherical droplets ranging from few tens of nanome-
ters up to several microns in diameter. These studies
are further aided by the fact that Raman spectroscopy
can easily distinguish between different lipids or lipid
states, such as saturated and unsaturated fatty acids,
triglycerides, oxidized lipids, etc. (see Figs. 3 and 4). At
the current time we simply have no other means to per-
form similar analyses of individual lipid droplets and
their prolonged development, in living cells. The anal-
ysis of such complex lipid mixtures, however, requires
additional advanced chemometricstechniques, such as
hierarchical cluster analysis or least discriminant anal-
ysis (LDA) in order to determine the precise lipid
composition of these structures
Coherent Raman imaging techniques are particu-
larly interesting on these length scales, because they
enable the rapid and repetitive imaging of cells as
they develop lipid inclusions, while also allowing for
the analysis of the lipid composition (Figs. 4 and 5
and references [49, 50]). This enables the acquisi-
tion of dynamic data on the second and sub-second
time scale as shown in the example of Nan et al.
who first demonstrated dynamic imaging of intracel-
lular organelle transport without exogenous dyes in
steroidogenic mouse adrenal cortical cells [51].
Another example demonstrating the utility of
Raman-based imaging is the tracking of the infection
pathways of Hepatitis C, which are very difficult, if not
impossible to study by other means. The Hepatitis C
Virus (HCV) is believed to spread by hiding inside
triglyceride-rich lipoprotein particles, such as very
low-density lipoproteins (VLDL). While some studies
have been conducted using fluorescent markers, such
exogenous labels may perturb and alter the behavior of
lipid droplets and their associated proteins. Nan et al.
for example, were able to correlate lipid droplet den-
sity with HCV density in human hepatoma cells using a
combination of fluorescence and CARS imaging [52].
More recently, Rinia and coworkers used multiplex
CARS microscopy to obtain quantitative images of
similar lipid droplets and measure the composition
and distribution of different species of lipids within
a single droplet. Their work demonstrated that cells
that took up lipids from their surrounding environment
formed small droplets that later fused with the larger
droplets that already resided in the cytoplasm [50].
This paper, as well as other similar work, has opened
up an entirely new way of studying lipid interactions
with cells. Coherent Raman microscopy is currently
the only technique capable of rapidly and quantita-
tively imaging lipid dynamics in living cells without
altering them. A challenge, however, remains the
Fig. 3. A) Differential interference contrast image of a human mesenchymal stem cell differentiatedinto an adipocyte as evident by the large
number of lipid droplets. B) Raman spectrum of the lipid droplet highlighted in A). The spectrum indicates the presence of mostly unsaturated
lipids in the form of di- and triglycerides.








Fig. 4. Human THP-1 monocytes treated with lipoprotein lipolysis products. A) CARS image of a monocyte at 2845 cm−1 exhibiting increased
saturated fatty acids in lipid inclusions as indicated by the associated Raman spectrum (B). C) CARS image of a monocyte with lipid droplets
consisting of mostly unsaturated fatty acids as indicated by the associated Raman spectrum (D).
a b
Fig. 5. a) Differential interference contrast image of a human mesenchymal stem cells differentiatedinto adipocytes containing many large lipid
droplets. b) CARS image of the area highlighted in a by scanning the sample at the 2845 cm−1 aliphatic lipid vibration. Scale bar: 5 m.
sensitivity limit of these techniques, which requires
sample concentrations in the high micromolar to mil-
limolar range. Overcoming this limitation requires
additional tricks, such as e.g. the application
of doubly-resonant CARS microscopy, where an
abundant Raman resonance can be utilized to amplify
the signal of a weaker resonance [53–55].
Lately, embryonic stem cells and their derivatives
have become a popular target or Raman-based stud-
ies [56]. Pluripotent cells carry a number of unique
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characteristics that show up in their Raman-
spectroscopic signature, i.e. as increased cytoplasmic
levels of glycogen and a distorted intranuclear protein-
DNA ratio, that can be used to characterize these cells,
determine their differentiation state, and, ideally isolate
them from the larger population of yet uncommitted
cells [57–59]. This is particularly important if these
cells are to be purified for therapeutic applications,
because e.g. antibody or aptamer-based biochemical
methods will activate and/or contaminate these cells.
Raman spectroscopy requires no reagents and has no
detrimental effects on cell health, which is why Raman-
based flow sorting would be highly desirable. This,
however, will likely again require the use of multiplex
coherent Raman technique in order to meet the time
scales required to efficiently sort large populations of
cells.
4. Raman scattering of tissues
4.1. Cancer diagnosis
Raman scattering has been used extensively to assess
disease states in tissues. As shown in the preceding
sections, Raman spectroscopy has been used to non-
invasively discriminate cancerous from noncancerous
cells in solution. This same ability can be extended
to tissues, where Raman spectroscopy can provide a
compelling complement to traditional dissection and
H&E (hematoxylin and eosin) staining. H&E staining
provides primarily structural information while Raman
spectroscopy and Raman imaging provide a detailed
picture of the underlying chemical changes that accom-
pany carcinogenesis.
Several groups have pursued this direction, with
promising results. In an early paper on the subject,
Mizuno et al. showed spectral changes associated with
glioma carcinogenesis, with quantitative spectral dif-
ferences being observed between grade II and grade III
disease [60]. Nijssen et al. demonstrated the ability of
Raman mapping, where Raman spectra are acquired at
hundreds of points on a section of tissue to form a low-
resolution hyperspectral image, to discriminate basal
cell carcinoma from surrounding normal tissue [61].
These results are shown in Fig. 6, adapted from [61].
Majumder et al. examined Raman spectroscopy and
two other optical biopsy techniques, namely autoflu-
orescence and diffuse reflectance, comparing their
ability to discriminate between normal breast tissue,
fibroadenoma, ductal carcinoma in situ, and invasive
ductal carninoma [62]. Their results show that although
autofluorescence and diffuse reflectance have the abil-
ity to classify samples, especially when used jointly,
Raman spectroscopy alone gives superior classification
accuracy, with a Hand and Till measure (an extension
of the traditional sensitivity and specificity metrics to
multiclass classification) of 0.99 (compared to an ideal
of 1.0). The examination of more than one class of
disease in this work is an important aspect to note.
Raman spectroscopy has shown considerable power in
discriminating between not just normal and diseased
tissue, but between different types and stages of dis-
ease. For example, Chowdary et al. demonstrated that
Fig. 6. Comparison of pseudo-color Raman maps (a, c) with images (b, d) of H&E-stained adjacent sections. Black = BCC; red and green = dermis;
blue = dense chronic inflammatory infiltrate. 1 = BCC; 2 = collagen-poor dermis; 3 = collagen-rich dermis; 4 = chronic inflammatory infiltrate.
Scale bar: 100 m. Reprinted by permission from Macmillan Publishers Ltd: Journal of Investigative Dermatology, Ref. 61, 2002.
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Raman spectroscopy can distinguish between benign
and malignant lesions within breast tissue [63].
One factor that is common to all of the above
studies is a reliance on multivariate statistical meth-
ods for extracting meaningful information from the
information rich Raman spectrum. Although Raman
spectroscopy is typically hailed for its ability to pro-
vide an information-rich spectrum, the same chemical
specificity which allows it to classify samples with high
accuracy can also make real-world application of the
technique challenging. Typical multivariate models are
generated by measuring hundreds of spectra from hun-
dreds of samples, and then submitting this information
to a machine learning algorithm that searches for cor-
relations between spectra that have been defined as
belonging to a specific class. A new, unrelated set of
spectra (the so-called validation set) is then submitted
to the trained algorithm and the samples are classi-
fied based on the features and correlations deduced
from the training set. Extension of these multivariate
models to spectra taken on different instruments, by
different users, or on different patients, is a problem
known as calibration transfer. The challenges of cali-
bration transfer is one reason why Raman spectroscopy
has not seen more widespread adoption in clinical set-
tings. The sensitivity of Raman spectroscopy means
that a spectrum reports on all variations between one
patient and another, most of which are unrelated to
disease state and generally serve only to confound the
multivariate model. The group of Mahadevan-Jansen
has extensively examined the spectral changes between
samples that are all labeled histologically normal [64,
65]. In these works, the authors have shown that there
are strong spectral differences in the cervix related to
both menopausal status and position within the men-
strual cycle. In addition, there are differences between
the Raman spectra from cervices that have had a pre-
vious history of disease versus those that might be
thought of as “true normals”.
Several groups have explored various methodolo-
gies to reduce this potentially confounding biological
variability. One technique explored by Chen et al.
involves measuring cells scraped from the colon lin-
ing ex vivo, as single cells stripped of the surrounding
tissue components often show much lower biologi-
cal variability [43]. Smith and Berger demonstrated a
technique using polarization to select only those pho-
tons which have explored the most superficial layers
of tissue. Since many tumors reside in the surface
layers of tissue, this could reduce variability arising
from spectral components in the deeper layers of tis-
sue [66]. Matousek and Stone have explored various
novel instrument geometries that have the potential to
reduce confounding artifacts. In one paper, they have
shown the ability of a Raman system to detect a cal-
cified inclusion within a thick layer of tissue, with
potential applications to breast cancer diagnosis [67].
Matousek has also pioneered spatially offset Raman
spectroscopy (SORS), where excitation photons are
launched from an optical fiber into a tissue at one loca-
tion and collected through a second fiber at a small
distance from the source fiber. The distance between
the source and collection fiber determines the volume
explored by the measurement. Through appropriate
choice of source-collection distances, one can make
depth-resolved measurements of the bulk tissue, poten-
tially removing biological variability by suppressing
signal from pathologically uninteresting layers [68].
One intriguing result of Raman spectroscopy’s
exquisite chemical sensitivity is the prospect of using
Raman spectroscopy to detect the cancer field effect.
First described in 1953 [69], the cancer field effect
describes both a situation in which a cancerous cell
exerts an influence on its surrounding environment, as
well as the idea that carcinogenesis is a symptom of
a broader, tissue-level disorder. The cancer field effect
has been compellingly explored optically by Backman
et al. [70] through the use of elastic light scattering.
However, two studies have pointed to the potential of
Raman spectroscopy to detect the changes in tissue
chemistry of normal tissue due to the presence of can-
cerous cells in the vicinity [65, 71]. Most compellingly,
Lieber et al. have recently demonstrated that spectral
differences can be found between normal organotypic
raft cultures that have been cultured either in the pres-
ence or absence of cancer cells. It is important to note
that the cancer cells in these studies were not in phys-
ical contact with the raft cultures, but rather simply
shared culture media, providing a conduit for cell-cell
signaling.
The preceding studies all utilized spontaneous
Raman spectroscopy to perform cancer diagnosis. But
it is important to note that some work has been done
using coherent variants of Raman spectroscopy as well.
Ji-Xin Cheng and co-authors recently published a com-
pelling article utilizing the previously described CARS
imaging technique to perform intravital flow cytome-
try - where cytometry is performed on cells flowing
through a single capillary in vivo – using CARS imag-
ing of a lipid resonance as a contrast mechanism to
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detect circulating tumor cells [72]. Demonstrating the
feasibility of detecting CTCs using CARS imaging has
obviously important implications for cancer detection
and treatment.
These important studies point to Raman spec-
troscopy’s power to diagnosis cancer based on the
chemical changes undergone during the process of
carcinogenesis. Although challenges remain in using
appropriate multivariate techniques to extract mean-
ingful variations within the complicated Raman spectra
from the uninteresting variations occurring due to nor-
mal biological processes, the prospects for in vivo
diagnosis of cancer through Raman biopsy are promis-
ing.
4.2. Raman spectroscopy of vasculature
A particular application of Raman spectroscopy is
to detection of vulnerable plaques and other coronary
diseases. Several early papers by Michael Feld and
co-authors [73, 74] established the ability of Raman
spectroscopy to detect spectral differences between
normal coronary tissues and various plaques, includ-
ing calcified, fibrous, and atheromatous plaques based
on samples studied ex vivo. These signals were cor-
related with results from biochemical assays, with the
excellent agreement pointing to Raman spectroscopy’s
power as a quantitative assay technique. These results
were replicated in vivo by Buschman et al. in an animal
model utilizing specially designed fiber probes allow-
ing high quality Raman signals to be detected through
long segments of optical fiber [75]. More recently,
Motz et al. measured in vivo spectra of arterial plaques
during peripheral vascular surgery. Spectra taken were
analyzed by fitting acquired spectra to a model com-
posed of 9 chemical constituents. The results were
then compared with traditional morphological assess-
ment during routine confirmational histology. The
results indicated the ability of Raman spectroscopy to
diagnose in vivo several arterial pathologies includ-
ing intimal fibroplasia, atheromatous plaques, calcified
plaques, ruptured plaques, and thrombotic plaques
[76]. Further in vivo results have been presented utiliz-
ing both fingerprint and high-wavenumber spectra of
a human artery through the use of a specially designed
fiber probe [77].
Meanwhile, CARS has very recently been demon-
strated in an ex vivo human artery [78]. CARS, in
conjunction with two-photon fluorescence and sec-
ond harmonic generation, provide an image with some
chemical sensitivity. False color images were demon-
strated where two-photon fluorescence reports mainly
on elastin, second harmonic generation reports on col-
lagen, while CARS signals are mainly due to lipid
content.
The ability of Raman spectroscopy to diagnose
vulnerable plaques has been the subject of much
promising study for over 20 years. However, only
recently has it become feasible to create fiber probes
both small and flexible enough to enter a human artery
while still retaining the ability to acquire high quality
Raman signals with integration times on the scale of 1
second or less.
4.3. Other applications of Raman spectroscopy
to tissue
Raman spectroscopy has found applications beyond
those major topics discussed above. Due to its chemical
sensitivity it can be used in many applications where
morphology alone is not enough to determine dis-
ease type. Gniadecka et al. have shown that cutaneous
tophi and calcinosis, two nodule forming pathologies
with similar clinical presentations, can be diagnosed
quite easily through the presence of monosodium urate
bands or hydroxyapatite bands within the Raman spec-
trum [79].
In a recent study regarding wound healing,
Crane et al. demonstrated that Raman spectra of severe
wounds sustained by service members in Operations
Iraqi Freedom and Enduring Freedom have predictive
ability with regards to whether the wounds will heal
normally or have impaired healing [80]. This is princi-
pally a function of the collagen content of the wounds,
with impaired healing wounds lacking adequate col-
lagen deposition. They also show the evolution of the
Raman spectra of tissue removed from a normal heal-
ing wound at the first and last debridement, shown in
Fig. 8 (adapted from [80]).
The ability to noninvasively monitor wound health is
undoubtedly a pressing unmet need in hospital settings.
Another application is the determination of chem-
ical profiles of particular analytes within tissue.
For example, Caspers et al. used confocal Raman
microspectroscopy to determine the hydration level of
skin versus depth [81], reporting on several analytes
comprising the so-called natural moisturizing factor.
Concentration profiles such as these could be used to










































Fig. 7. Coherent Anti-Stokes Raman Scattering (CARS) microscopy of mouse aorta thin section stained with H&E stain and oil-red O. A)
White light transmitted light micrograph of the stained tissue section. Oil-red O stained lipids appear red. B) Time-correlated CARS image of
the same tissue section. Areas with a photon arrival time within the instrument response function of the system appear green, while delayed
photons due to fluorescence appear red. Spectra obtained from the highlighted areas are shown to the right. The sharp peak at 665 nm in (I)
represents a CARS peak from the 2845 cm−1 Raman mode of aliphatic C–H bonds representative of lipids. The spectrum obtained in area (II)
exhibits no CARS contributions and only broad fluorescence background. This is additional proof that the green areas shown in (B) are entirely
due to CARS signals from lipids. C) Time-gated CARS micrograph of the same tissue section. Time-gating for photons arriving within the fast
instrument response selects on CARS signals and rejects any fluorescence contributions. D) Overlay of the transmitted light image (A) with the
time-gated CARS image (C).
monitor, for example, drug delivery from a topically
applied solution.
Coherent techniques have a role to play in this area
as well. In 2005, Evans et al. demonstrated video-rate
CARS imaging of lipids in vivo [82]. As discussed in
that article, the technique opens up possibilities for real
time imaging of drug diffusion and metabolism as well
as other pathologically relevant applications.
5. Pathogen analysis by Raman spectroscopy
Raman spectroscopy has been used in several appli-
cations for pathogen analysis and typing. The ability
of Raman spectroscopy to measure bacteria either on
culture medium, in situ, or to measure single bacte-
ria in solution has the potential to greatly reduce the
need for labor and time-intensive culturing of bacte-
ria on selective media to determine the identity of a
particular pathogen.
Andrew Berger and co-authors have done extensive
research on oral bacteria, showing the ability of Raman
spectroscopy to quantify different bacterial species in
polymicrobial mixtures [83] and in intact biofilms [19].
The ability to separate different bacterial species in a
native, mixed environment demonstrates the power of
Raman spectroscopy to rapidly characterize pathogens
without waiting for culture.
Rösch et al. further this technique by extending it
to Raman spectra of single bacteria, such as might be
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Fig. 8. Visible images of tissue sections for a normal healing wound at first (A) and last (D) debridements. Corresponding score images (B and
E) and components (C and F) are shown. Each pixel in the score image is approximately 100 × 100 m. Adapted with permission from Ref. 80.
found on the air filter in a clean room environment
[21]. Through the use of support vector machines, a
multivariate machine learning algorithm, the authors
report recognition rates for different bacterial species
of over 90%. The authors also record high resolution
Raman maps of the single bacteria and bacterial spores.
The hyperspectral maps, shown in Fig. 9 (adapted from
[21]), clearly show spatial variation of band intensi-
ties across the bacterium, information which could be
utilized in studies of bacterial growth or metabolism.
Intriguingly, the authors also claim ∼80–90% clas-
sification accuracy for recognizing different strains of
the same bacterial species. This important result was
replicated on a different system by Maquelin et al. for
different strains of Acinetobacterbaumannii, a major
cause of hospital infections [84]. Using isolates from
five known hospital outbreaks of the bacterium, Raman
spectra were recorded alongside genetic analyses. By
simply smearing the bacteria onto a CaF2 slide and
measuring the spectrum, then submitting the measured
spectra to a simple principal components/hierarchical
clustering analysis, the bacteria could be typed by
strain with only one misclassification out of 25 sam-
ples.
Neugebauer et al. explored the spatial variation
of Raman spectra within bacteria using tip-enhanced
Raman spectroscopy (TERS) to provide exquisite spa-
tial localization [85]. TERS is closely related to the
above-described surface-enhanced Raman scattering,
where a metal tip provides the plamon resonance and
field enhancement. By scanning a silver-coated sili-
con tip with a nominal apex diameter of 50 nm, TERS
spectra were acquired across a bacterium with spa-
tial resolutions limited only by the tip diameter. This
provides the possibility to examine dynamics and pro-
cesses that occur directly on the surface of the bacterial
wall, and important site of attack for many antibi-
otics, and an important point of antibiotic defense for
drug resistant bacteria. This was further explored in a
later paper where time-dependent fluctuations of TERS
peaks were observing a single point on a bacterial cell
wall [86].
CARS has also been used for imaging of bacterial
spores. In Fig. 10, the image of spores takes advan-
tage of a strong Raman resonance at 1013 cm−1 due to
calcium dipicolinate in dormant spores.
Several groups have investigated the ability of
Raman spectroscopy to elucidate mechanisms of
action of antibiotics. As described in a paper by López-
Diez et al. the rate at which new antibiotics are being
developed is declining while the rate at which many
important human pathogens are acquiring multi-drug
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Fig. 9. Raman maps of a single bacterium (B. sphaericus DSM 28) for three different wavenumber regions: a, 2851 to 2964 cm−1; b, 1604 to
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Fig. 10. A) Raman spectrum of bacterial spores of Bacillus subtilis. The strong peak at 1013 cm−1 is due to calcium dipicolinate in the dormant
spores. B) The beams of two picosecond lasers were tuned to the calcium dipicolinate vibration resulting in strong coherent anti-Stokes Raman
scattering at 697 nm. C) CARS image the bacterial spores adhered to a glass surface when imaged at the 697 nm resonance.
resistance is increasing [87]. Therefore, there is a press-
ing need for tools to enable rapid drug development
and characterization, as well as a need for tools within
a hospital environment to determine if a particular drug
is an effective antibiotic agent for a particular patient
or outbreak. In the López-Diez paper, the authors use
UV resonance Raman spectroscopy, which preferen-
tially reports on bands associated with nucleic acids
and amino acids, to assess chemical changes upon
treatment of Pseudomonas aeruginosa with amikacin.
The results show that not only do the spectra report on
known rRNA damage and associated protein synthe-
sis inhibition, but they also can quantitatively separate
inhibitory versus subinhibitory concentrations of the
drug. Moritz et al. have also reported on Raman spec-
troscopic markers of drug action in a study examining
the effect of cefazolin on individual, living E. coli bac-
teria [88]. Through monitoring the bacteria at different
time points along their growth curve, spectral changes
are noted that correlate strongly to the concentration
of drug applied. This has led the authors to hypoth-
esize that one mechanism of action of cefazolin may
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be related to non-enzymatic glycosylation of the bac-
terial DNA, leading to an abnormal arrest of bacterial
replication by causing the bacteria to enter stationary
phase.
Besides the obvious industrial utility of helping
to assess toxicity of candidate drugs and helping to
elucidate mechanisms of drug action, the ability to
noninvasively characterize the response of individual
bacteria to antibiotics may provide valuable insight
to a clinician in helping to determine an appropriate
course of treatment for a particular patient, enabling
more targeted and efficacious therapies.
6. Conclusions and outlook
Raman scattering in pathology is still a relatively
new science. Its potential has been demonstrated so far
for a range of applications, including label-free analy-
sis of cells, tissues, and detection of certain pathogens.
After initially relatively slow adoption, an increasing
number of studies have incorporated Raman scattering
for characterization of cancer cells, microbiological
cultures, and to determine the interactions of drugs with
cells, especially in cases where fluorescent probes are
not suitable (small molecules) or are limiting due to
e.g. photo-bleaching. For rapid live cell imaging dif-
ferent modalities of coherent Raman scattering are now
widely utilized and are even available from commer-
cial sources. These methods are now also beginning
to find their way into the latest areas of biomedical
research, such as regenerative medicine, where bio-
chemical methods can often do more harm than good.
Another area of intense research is the development
of portable, fiber-based Raman devices that enable the
use of Raman spectroscopy for in-vivo endoscopies,
in clinical settings, or in the field, with potential for
real-time optical biopsy in pathology. While this is
a very exciting direction, problems such as intrinsic
fluorescence signal generated in the tissue by the exci-
tation laser, and background Raman and fluorescence
signals produced by most fibers when the excitation
light passes through them will have to properly be
addressed.
A particularly interesting prospect for Raman spec-
troscopy is its ability to utilize minor changes in
molecular structure to create unique optical mark-
ers, similar to fluorescent labels, but significantly less
intrusive and at the same time robust to photode-
composition. A relatively easy to implement change
in molecular structure is for example the isotope-
exchange of deuterium for hydrogen. In deuterated
molecules, the high wavenumber active C-H bond in
the 2850 cm−1 range is shifted to significantly lower
wavenumbers of ∼2200 cm−1 for C-D vibrations. Fur-
thermore, this signal occurs in a spectral region that
for most biomolecules is entirely flat and featureless.
Thus, this marker peak now enables one to isolate and
track deuterated molecules and distinguish them from
the bulk of non-modified molecules. This is partic-
ularly useful for small molecules, such as lipids or
sugars, the function and processing of which would
otherwise be significantly limited by the need to attach
large fluorescent molecules to them.
Another potential prospect is the advent of super-
resolving methods in fluorescence microscopies, i.e.,
optical tools that make imaging beyond the diffrac-
tion limit possible. The most prominent current
implementation of these far-field super-resolving
methods are stimulated emission depletion (STED),
single molecule localization techniques, and struc-
tured illumination microscopy. STED could possibly
be implemented in coherent Raman imaging modal-
ities, whereas structured illumination is compatible
with spontaneous Raman spectroscopy. First propos-
als to develop these modalities have been published but
it remains to be seen how these will be implemented
practically in the future.
In addition, combination of Raman scattering
with other methods including immunohistochemistry,
flow cytometry, laser capture micro-dissection, and
quantitative imaging is very attractive for enhanced
sensitivity and specificity of detection. In many cases,
Raman scattering can be utilized alongside traditional
sample collection and analysis techniques to provide
an additional dimension of information.
In conclusion, Raman scattering is a powerful
technique, which can monitor subtle biochemical
changes within cells and tissues without the need
for invasive labels. Despite challenges involving low
signal strengths and competing backgrounds, Raman
spectroscopy has already been applied to several prob-
lems of clinical interest for pathologists. However,
closer collaborations between pathologists and spec-
troscopists is needed to identify and approach unmet
clinical needs in pathology to bring Raman scattering
out of laboratory environments and into widespread
clinical practice.
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